Skip to content

Does the new disposable distal attachment (Endocuff) improve detection of pre cancerous polyps?

Is EndocuffTM Vision assisted colonoscopy superior to Cap assisted colonoscopy to detect adenomas?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58994883
Enrollment
154
Registered
2017-07-12
Start date
2016-04-15
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic polyps detection Digestive System Polyp of colon

Interventions

This is a back to back study to compare the Cap and Endocuff to detect polyps during colonoscopy. Each patient will undergo two consecutive colonoscopies by the same endoscopist in a randomised order

Sponsors

London North West Healthcare NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults over the age of 18 years undergoing a colonoscopy

Exclusion criteria

Exclusion criteria: 1. Absolute contraindications to colonoscopy 2. Established or suspicion of large bowel obstruction or pseudo-obstruction 3. Known colon cancer or polyposis syndromes 4. Known colonic strictures 5. Known severe diverticular segment (that is likely to impede colonoscope passage) 6. Patients with active colitis (ulcerative colitis, Crohn’s colitis, diverticulitis, infective colitis) 7. Patients lacking capacity to give informed consent 8. Pregnancy 9. Patients who are on clopidogrel, warfarin, or other new generation anticoagulants/antiplatelets who have not stopped this for the procedure.

Design outcomes

Secondary

MeasureTime frame
1. Caecal intubation time and withdrawal time, collected using case report form at baseline 2. Discomfort during the procedure, measured using standard scoring system used routinely in endoscopy units on a 5-point discomfort scale, collected at baseline 3. Removal rate of cap and Endocuff, collected using case report form at baseline

Primary

MeasureTime frame
1. Polyp miss rate, calculated at the end of the study period 2. Adenoma miss rate, calculated at the end of the study period

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026